Big Pharma is waging a war on generics. It's time to end it.
PCMA's new campaign exposes how drugmakers use patent thickets and other tactics to delay lower-cost generic and biosimilar competition and keep prescription drug prices high.
Watch the latest ad below and learn more at WarOnGenerics.com
PCMA's new campaign exposes how drugmakers use patent thickets and other tactics to delay lower-cost generic and biosimilar competition and keep prescription drug prices high.
Watch the latest ad below and learn more at WarOnGenerics.com
0:30